Poststroke neuropsychiatric illness: An integrated approach to diagnosis and management

Current Treatment Options in Neurology

Volumn 6, Issue 5, 2004, Pages 403-420

  Bourgeois, James A ^a   Hilty, Donald M ^a   Chang, Celia H ^a   Wineinger, Mark A ^a   Servis, Mark E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMFEBUTAMONE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIOXIDANT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CHOLINESTERASE INHIBITOR; CITALOPRAM; DESIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; MAPROTILINE; METHYLPHENIDATE; MIANSERIN; MIRTAZAPINE; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ALZHEIMER DISEASE; ANOREXIA; ANXIETY DISORDER; APATHY; ARTICLE; ASTHENIA; BODY WEIGHT DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONFUSION; CONSTIPATION; DELIRIUM; DEMENTIA; DEPRESSION; DIAGNOSTIC TEST; DIARRHEA; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; ELECTROCONVULSIVE THERAPY; EMOTIONAL DISORDER; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH SURVEY; HUMAN; HYPERTENSION; HYPOTENSION; INSOMNIA; MEDICAL LITERATURE; MENTAL DISEASE; MOOD DISORDER; MULTIINFARCT DEMENTIA; MUSCLE CRAMP; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; NEUROLOGY; NEUROPATHOLOGY; PATIENT REFERRAL; PSYCHIATRY; PSYCHOSIS; PSYCHOTHERAPY; RISK ASSESSMENT; SCREENING TEST; SEDATION; SEXUAL DYSFUNCTION; SOMNOLENCE; TREATMENT PLANNING; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 4544349582     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-996-0031-9     Document Type: Article

References (84)

1. Robinson RG, Chemerinski E, Jorge R: Pathophysiology of secondary depressions in the elderly. J Geriatr Psychiatry Neurol 1999, 12:128-136.
2. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington DC, American Psychiatric Association, 2000.
3. Chemerinski E, Robinson RG: The neuropsychiatry of stroke. Psychosomatics 2000, 41:5-14.
4. Robinson RG: Neuropsychiatric consequences of stroke. Ann Rev Med 1997, 48:217-229.
5. Starkstein SE, Bryer JB, Berthier ML, et al.: Depression after stroke: the importance of cerebral hemisphere asymmetries. J Neuropsychiatry Clin Neurosci 1991, 3:276-285.
6. Herrmann M, Schumacher M: Poststroke depression: is there a pathoanatomic correlate for depression in the postacute stage of stroke? Stroke 1995, 26:850-856.
7. Iacoboni M, Padovani A, Di Petro V, Lenzi GL: Poststroke depression: relationships and morphological damage and cognition overtime. Ital J Neurol Sci 1995, 16:209-216.
8. Robinson RG, Starkstein SE: Current research in affective disorders following stroke. J Neuropsychiatry Clin Neurosci 1990, 2:1-14.
9. Kishi Y, Robinson RG, Kosier JT: The validity of observed depression as a criteria for mood disorders in patients with acute stroke. J Aff Disord 1996, 40:53-60.
10. House A: Depression associated with stroke. J Neuropsychiatry 1996, 8:453-457.
11. MacHale SM, O'Rourke SJ, Wardlaw JM, Dennis MS: Depression and its relation to lesion location after stroke. J Neurol Neurosurg Psychiatry 1998, 64:371-374.
12. Singh A, Herrmann N, Black SE: The importance of lesion location in poststroke depression: a critical review. Can J Psychiatry 1998, 43:921-927.
13. Gainotti G, Marra C: Determinants and consequences of poststroke depression. Curr Opinion Neurol 2002, 15:85-89.
14. Gustafson Y, Nilsson I, Mattsson M, et al.: Epidemiology and treatment of poststroke depression. Drugs Aging 1995, 7:298-309.
15. Rummans TA, Lauterbach EC, Coffey CE, et al.: Pharmacologic efficacy in neuropsychiatry: a review of placebo-controlled treatment trials. J Neuropsychiatry Clin Neurosci 1999, 11:176-189.
16. Gall A: Post stroke depression. Hosp Med 2001, 62:268-273. III
17. Gordon WA, Hibbard MR: Poststroke depression: an examination of the literature. Arch Phys Med Rehabil 1997 78:858-663. III
18. Rao R: Cerebrovascular disease and late life depression: an age old association revisited. Int J Geriatr Psychiatry 2000, 15:419-433. III
19. Burvill P, Johnson G, Jamrozik K, et al.: Risk factors for poststroke depression. Int J Geriatr Psychiatry 1997, 12:219-226. III
20. Ramasubbu R, Robinson GR, Flint AJ, et al.: Functional impairment associated with poststroke depression: the Stroke Data Bank study. J Neuropsychiatry Clin Neurosci 1998, 10:26-33. II
21. Fedoroff JP, Robinson RG: Tricyclic antidepressants in the treatment of poststroke depression. J Clin Psychiatry 1989, 50(Suppl 7):S18-S23. III
22. Black-Schaffer RM, Kirsteins AE, Harvey RL: Stroke rehabilitation. 2. Co-morbidities and complications. Arch Phys Med Rehabil 1999, 80(Suppl):S8-S16. III
23. Rigler SK: Management of poststroke depression in older people. Clin Geriatr Med 1999, 15:765-783. III
24. Clark MS, Smith DS: The effects of depression and abnormal illness behavior on outcome following rehabilitation from stroke. Clin Rehabil 1998, 12:73-80. II
25. Ramasubbu R: Relationship between depression and cerebrovascular disease: conceptual issues. J Aff Disord 2000, 57:1-11.III
26. Gottleib D, Salagnik I, Kipnis M, Brill S: Post stroke depression, first year post stroke, in middle band patients. Int J Geriatr Psychiatry 2002, 17:486-487.
27. Schubert DSP, Taylor C, Lee S, et al.: Physical consequences of depression in the stroke patient. Gen Hosp Psychiatry 1992, 14:69-76.
28. Paolucci S, Antonucci G, Pratesi L, et al.: Poststroke depression and its role in rehabilitation of inpatients. Arch Phys Med Rehabil 1999, 80:985-990.
29. Gianotti G, Antonucci G, Marra G, Paolucci S: Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001, 71:258-261.
30. Gianotti G, Azzoni A, Razzano C, et al.: The Poststroke Depression Rating Scale: a test specifically devised to investigate affective disorders of stroke patients. J Clin Experiment Neuropsychology 1997, 19:340-356.
31. Kishi Y, Robinson RG, Kosier JT: Suicidal ideation among patients during the rehabilitation period after life-threatening illness. J Nerv Ment Dis 2001, 189:623-628.
32. Krishnan KRR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997, 154:497-501.
33. Alexopoloulos GS, Meyers BS, Young RC, et al.: Clinically defined vascular depression. Am J Psychiatry 1997, 154:562-565.
34. Wassertheil-Smoller S, Applegate WB, Berge K, et al.: Change in depression as a precursor of cardiovascular events. Arch Int Med 1996, 156:553-561.
35. Krishnan KRR: Depression as a risk factor for cardiovascular and cerebrovascular disease: emerging data and clinical perspectives. Am Heart J 2000, 140(Suppl):S70-S76.
36. Raskind MA: The clinical interface of depression and dementia. J Clin Psychiatry 1998, 59(Suppl 10):9-12.
37. Dam M, Tonin P, De Boni A, et al.: Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996, 27:1211-1214.
38. Cheer SM, Goa KL: Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. Drugs 2001, 61:81-110.
39. Dahmen N, Marx J, Hopf HC, et al.: Therapy of early poststroke depression with venlafaxine: safety tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke 1999, 30:691-692.
40. Lauritzen L, Bendsen BB, Vilmar T, et al.: Poststroke depression: combined treatment with imipramine or desipramine and mianserin: a controlled clinical study. Psychopharmacology 1994, 114:119-122.
41. Staab JP, Evans DL: Efficacy of venlafaxine in geriatric depression. Depression Anxiety 2000, 12(Suppl 1):63-68.
42. Harvey SA, Black KJ: The dexamethasone suppression test for diagnosing depression in stroke patients. Ann Clin Psychiatry 1996, 8:35-39.
43. Starkstein SE, Federoff P, Berthier ML, Robinson RG: Manic-depressive and pure manic states after brain lesions. Biol Psychiatry 1991, 29:149-158.
44. Robinson RG, Boston JD, Starkstein SE, Price TR: Comparison of mania and depression after brain injury: causal factors. Am J Psychiatry 1988, 45:172-178.
45. Kaye JA: Diagnostic challenges in dementia. Neurology 1998, 51(Suppl 1):S45-S52.
46. Roman GC, Tetemichi TK, Erkinjuntti T, et al.: Vascular dementia: diagnostic criteria for research studies. Neurology 1993, 43:250-260.
47. Moroney JT, Bagiella E, Tatemichi TK, et al.: Dementia after stroke increases the risk of long-term recurrence. Neurology 1997, 48:1317-1325.
48. Rockwood K, Wentzel C, Hachinski V, et al.: Prevalence and outcomes of vascular cognitive impairment. Neurology 2000, 54:447-452.
49. Desmond DW, Moroney JT, Paik MC, et al.: Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000, 54:1124-1131.
50. Downhill JE, Robinson RG: Longitudinal assessment of depression and cognitive impairment following stroke. J Nerv Ment Dis 1994, 182:425-431.
51. Katz IR: Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias. J Clin Psychiatry 1998, 59(Suppl 9):S38-S44.
52. Robinson RG, Morris PLP, Fedoroff JP: Depression and cerebrovascular disease. J Clin Psychiatry 1990, 51(Suppl 7):S26-S31.
53. Kumar V, Anand R, Messina J, et al.: An efficacy and safety analysis of Exelon in Alzheimer's disease patents with concurrent vascular risk factors. Eur J Neurology 2000, 7:159-169.
54. Mendez MF, Younesi FL, Perryman KM: Use of donepezil for vascular dementia: preliminary clinical experience. J Neuropsychiatry Clin Neurosci 1999, 11:268-270.
55. Li Y, Meyer JS, Haque MA, et al.: Feasibility of vascular dementia treatment with cholinesterase inhibitors. Int J Geriatr Psychiatry 2002, 17:193-196.
56. Schultz SK, Castillo CS, Kosier JT, Robinson RG: Generalized anxiety and depression: assessment over 2 years after stroke. Am J Geriatr Psychiatry 1997, 5:229-237.
57. Robinson RG: Psychiatric management of stroke. Psychiatric Ann 2002, 32:121-127.
58. Derex L, Ostrowsky K, Highoghossian N, Trouillas P: Severe pathological crying after left anterior choroidal artery infarct: reversibility with paroxetine treatment. Stroke 1997, 28:1464-1466.
59. Kim JS: Pathological laughter and crying in unilateral stroke. Stroke 1997, 28:2321-2322.
60. Staub F, Bogousslavsky J: Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis 2001, 12:75-81.
61. Kotila M, Numminen H, Waltimo O, Kaste M: Depression after stroke: results of the FINNSTROKE study. Stroke 1998, 29:368-372.
62. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
63. Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression inventory: twenty-five years of evaluation. Clin Psychology Rev 1988, 8:77-100.
64. Johnson G, Burvill PW, Anderson CS, et al.: Screening instruments for depression and anxiety following stroke: experience in the Perth community study. Acta Psychiatr Scand 1995, 91:252-257. II
65. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
66. De Koning I, van Kooten F, Dippel DWJ, et al.: The CAMCOG: a useful screening instrument for dementia in stroke patients. Stroke 1998, 29:2080-2086.
67. Hilty DM, Hales RE, Kunkel EJS, et al.: Rational selection of antidepressants in primary care. Primary Psychiatry 2001, 8:50-57.
68. Lincoln NB, Flannahan T, Sutcliffe L, Rother L: Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil 1997, 11:114-122.
69. Hibbard MR, Grober SE, Gordin WA, et al.: Cognitive therapy and the treatment of poststroke depression. Top Geriatr Rehabil 1990, 5:43-55.
70. Sano M, Ernesto C, Thomas RG, et al.: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New Engl J Med 1997, 336:1216-1222.
71. Hinton L, Benjamin L, Bourgeois JA: Dementia: practical strategies for primary care. Primary Psychiatry 2001, 8:83-87.
72. Reding MJ, Orto LA, Winter SW, et al.: Antidepressant therapy after stroke. A double-blind trial. Arch Neurol 1986, 43:763-765.
73. Lipsey JR, Robinson RG, Pearlson GD, et al: Nortriptyline treatment of poststroke depression: a double-blind study. Lancet 1984, 1:297-300.
74. Robinson RG, Schultz SK, Castillo C, et al.: Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000, 157:351-359.
75. Wiart L, Petit H, Joseph PA, et al.: Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000, 31:1829-1832.
76. Andersen G, Vestergaard K, Lauritzen L: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994, 25:1099-1104.
77. Grade C, Redford B, Chrostowski J, et al.: Methylphenidate in early poststroke recovery: a double-blind, placebo - controlled study. Arch Phys Med Rehabil 1998, 79:1047-1050.
78. Masand P, Murray GB, Pickett P: Psychostimulants in poststroke depression. J Neuropsychiatry Clin Neurosci 1991, 3:23-27.
79. Lazarus LW, Moberg PJ, Langsley PR, et al.: Methylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison. Arch Phys Med Rehabil 1994, 75:403-406.
80. Lingam VR, Lazarus LW, Groves L, et al.: Methylphenidate in treating poststroke depression. J Clin Psychiatry 1988, 49:151-153.
81. Palomaki H, Kaste M, Berg A, et al.: Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 1999, 66:490-494.
82. Rasmussen A, Lunde M, Sorensen K, et al.: A double-blind, placebo-controlled study of Sertaline in the prevention of depression in stroke patients. Paper presented at the Annual Meeting of the American Psychiatric Association. 2002.
83. Balunov OA, Sadov OG, Alemasova A: Therapy of depressions in poststroke patients. Alaska Med 1990, 32:20-29.
84. Narushima R, Kosier JT, Robinson RG: Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002, 190:296-303.